Plus   Neg

Stratec HY Adj. Profit Increases

Stratec SE reported that its adjusted consolidated net income from continuing operations for the first six months of the 2019 increased 37.9% to 10.3 million euros from 7.5 million euros last year. Adjusted earnings per basic share from continuing operations for the period rose by 36.5% to 0.86 euros, from 0.63 euros in the previous year.

Adjusted EBIT grew 40.4% to 12.7 million euros from 9.1 million euros in the prior year.

Consolidated sales increased 24.1% to 110.4 million euros from 88.9 million euros last year. On a constant currency basis, sales grew 21.7%. The sales growth was driven in particular by higher numbers of systems called up, as well as by increased sales with development and services.

The company still expects sales growth adjusted for exchange rate effects of at least 12% in 2019 and an adjusted EBIT margin of around 14% to 15%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Tuesday unveiled a new international collaboration for simultaneous review and approval of cancer drugs along with the agency's Australian and Canadian counterparts. The simultaneous approval of cancer therapies by the three regulators is intended to accelerate the process of making these new treatments available to patients around the world. Humanscale Corp. recalled about 24,900 units of QuickStand Lite workstations for concerns of injury hazard. These include about 2,200 units sold in Canada. The recalled workstation's arm can break and cause the workstation to fall, posing a risk of injury. The company has already received 52 reports of the arm breaking, including 12 reports of minor injuries. Facebook has revealed more details on the structure of an independent "oversight board" that will make final decisions about what posts stay up or come down, even if the company disagrees. The new "Oversight Board" will govern appeals from both Facebook and its users.
Follow RTT